Author Archive: AZBio

Castle Biosciences’ New Laboratory Receives Accreditation from College of American Pathologists

Posted on by

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its new state-of-the-art laboratory facility in Phoenix, AZ based on results of a recent onsite inspection as part of the CAP’s Accreditation Programs. 

Continue reading→

Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study

Posted on by

 Capstone Therapeutics Corp. (OTCQB:CAPS) (“the Company”) and LipimetiX Development, Inc., the Company’s drug development joint venture (“JV”) announced today that the JV’s lead commercial drug candidate, AEM-28-14, showed substantial and statistically-significant LDL cholesterol (LDLc) reductions in a hypercholesterolemic primate study at Wake Forest University.  Following a single IV administration of escalating doses up to 5mg/kg, LDLc exhibited a mean reduction of 64% from baseline at 24 hours, 46% from baseline at 3 days and 16% from baseline at 7 days, despite the study animals remaining on a high fat/cholesterol diet through the full study.

Continue reading→

Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients

Posted on by

PHOENIX — Mayo Clinic has created a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma. The Lymph2Cx test helps determine where the lymphoma started, assigning “cell-of-origin” groups using a 20-gene expression-based assay. It is the first test to go into the Mayo practice from the new Mayo Clinic Molecular Diagnostic Arizona Laboratory. The lab enables Mayo physicians and researchers to access new and existing tests rapidly to improve patient care.Continue reading→

Dr. Leigh Neumayer named Interim Senior Vice president for Health Sciences

Posted on by

Leigh Neumayer, MD, MS, who heads the department of surgery at UA College of Medicine-Tucson, will be interim senior vice president for health sciences effective Jan. 1, 2017.  UA Heath Sciences includes UA’s medical schools in Phoenix and Tucson and the colleges of nursing, pharmacy and public health.The total UA Heath Sciences budget is $595 million per year.Continue reading→

SenesTech, Inc. Begins Trading on NASDAQ as SNES

Posted on by

SenesTech, Inc. (Nasdaq: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control based in Flagstaff, Arizona began public trading on December 8, 2017.  The  initial public offering of 1,875,000 shares of common stock priced at $8.00 per share. In addition, SenesTech and certain selling stockholders have granted the underwriters a 30-day option to purchase up to 281,250 additional shares of common stock at the initial public offering price, less the underwriting discount. Continue reading→

arivis AG named to 2016 Red Herring Top 100 Global

Posted on by

MUNICH, Dec. 8, 2016 /PRNewswire/ — Red Herring announced that it has named arivis AG, a leader in 3D+ imaging and compliance software for the life, health and material sciences, to its Top 100 Global. This award recognizes leading private companies from North America, Europe, and Asia, celebrating their innovations and technologies across their respective industries.Continue reading→